✦ LIBER ✦

N-acetyl-cysteine in the treatment of Parkinson’s disease. What are we waiting for?

✍ Scribed by Marcos Arturo Martínez-Banaclocha

Book ID: 116746417
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 221 KB
Volume: 79
Category: Article
ISSN: 0306-9877
DOI: 10.1016/j.mehy.2012.03.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Earlier Intervention in the Management o

Earlier Intervention in the Management of Hypercholesterolemia: What Are We Waiting For?

✍ Daniel Steinberg 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Clozapine for the treatment of psychosis

Clozapine for the treatment of psychosis in Parkinson's disease: a review

✍ P. Auzou; C. Özsancak; D. Hannequin; N. Moore; P. Augustin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

Discussion: Newer bisphosphonates in the

Discussion: Newer bisphosphonates in the treatment of paget's disease of bone: Where we are and where we want to go

✍ Andreas Grauer; Henry Bone; Eugene V. Mccloskey; Michael Mcclung; Donald H. Gutt 📂 Article 📅 1999 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 569 KB

Possible role for chlorpheniramine in th

Possible role for chlorpheniramine in the treatment of l-DOPA induced dyskinesia in Parkinson’s disease

✍ Karamanakos, Petros N. ;Pappas, Periklis ;Marselos, Marios 📂 Article 📅 2007 🏛 Springer 🌐 Dutch ⚖ 107 KB

PND62 What Are The Key Drivers for Chang

PND62 What Are The Key Drivers for Changing HTA Decisions? Example of Alzheimer'S Disease Treatment in Germany, France and UK

✍ J. Ackermann; M. Toumi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Treadmill training for the treatment of

Treadmill training for the treatment of gait disturbances in people with Parkinson’s disease: a mini-review

✍ T. Herman; N. Giladi; J. M. Hausdorff 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 249 KB